Is the hospital volume-mortality relationship in coronary artery bypass surgery the same for low-risk versus

Laurent G Glance1, Andrew W Dick, Dana B Mukamel

  • 1Department of Anesthesiology, University of Rochester Medical Center, School of Medicine and Dentistry, New York, Rochester 14642, USA. laurent_glance@urmc.rochester.edu

Insights

Low-risk patients gain the most benefit from high-volume centers for coronary artery bypass graft (CABG) surgery. High-risk patients also see improved outcomes at high-volume centers, though the benefit is less pronounced.

Area of Science:

  • Cardiovascular Surgery
  • Health Services Research
  • Outcomes Research

Background:

  • Evidence suggests an inverse relationship between coronary artery bypass graft (CABG) surgery mortality and procedure volume.
  • The differential benefit of high-volume centers for CABG surgery across varying patient risk levels remains unclear.

Purpose of the Study:

  • To investigate if patient risk modifies the association between CABG surgery volume and outcomes.
  • To determine if all patients equally benefit from undergoing CABG at high-volume centers.

Main Methods:

  • Retrospective cohort analysis of 20,078 CABG patients in New York State (1996 discharge data).
  • In-hospital mortality was the primary outcome, analyzed as a function of procedure volume.
  • Logistic regression modeling explored the interaction between patient risk and procedure volume.

Main Results:

  • A significant interaction (p=0.01) was found between CABG procedure volume and patient risk.
  • Low-risk patients experienced a greater reduction in mortality at high-volume centers compared to low-volume centers.
  • High-risk patients also showed better outcomes at higher-volume centers, particularly those with >25% mortality risk.

Conclusions:

  • Low-risk patients derive significant benefit from undergoing CABG surgery at high-volume centers.
  • High-risk patients also experience improved outcomes at high-volume centers, though the benefit is less pronounced than for low-risk patients.
  • Further validation using diverse regional databases is recommended before broader generalization.
Abstract